Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2025-03-27 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Sprawozdanie Zarządu z działalności (jednostkowe) xhtml.xades
Audit Report / Information Classification · 95% confidence The provided document text consists almost entirely of XML digital signature blocks (Signatures, SignedInfo, Reference, DigestValue, KeyInfo, X509Certificate, etc.). The key piece of information embedded within these signatures is the URI attribute of the Reference element, which points to a file named "Sprawozdanie_Zarz%C4%85du_Selvita_SA_Jednostkowe_26-03-2025.xhtml". The Polish phrase "Sprawozdanie Zarządu" translates to "Management Report". Furthermore, the document length is substantial (58,653 chars), indicating it is the content of the report itself, not just a short announcement about it. A Management Report (MDA) is defined as "Management's detailed explanation of financial results, business trends, and outlook." This classification fits the content described by the filename better than the general 'Interim/Quarterly Report' (IR) or 'Annual Report' (10-K), as 'Management Report' specifically covers the narrative explanation. Although the text is highly technical (XML signatures), the embedded filename strongly suggests the underlying document is a Management Report. FY 2024
2025-03-27 Polish
Sprawozdanie Zarządu z działalności (jednostkowe) xhtml
Audit Report / Information Classification · 95% confidence The provided document text is heavily truncated and appears to be the raw HTML/XML structure of a document, including CSS styles and font definitions, rather than the substantive content of a financial filing. The document length is extremely large (over 10 million characters), suggesting it is a full report, but the visible text is just boilerplate structure. However, the classification task requires identifying the document type based on content. Since the actual content (like '10-K', 'Annual Report', 'Earnings Release', etc.) is not visible, and the text is dominated by HTML/CSS structure, I must rely on the metadata and the general context of financial filings. Given the massive size (10,256,635 chars), this is almost certainly a comprehensive, full-length report, such as a 10-K or a very large Interim Report (IR). If the document were merely an announcement of a report, it would be short (RPA/RNS). Since it is massive, it is the report itself. Without specific keywords (like 'Item 1. Business' for 10-K or 'Consolidated Statements of Operations' for IR), distinguishing between 10-K (Annual) and IR (Interim) is difficult based only on the structural noise. In the absence of clear content markers, and given the sheer volume, the most comprehensive annual filing, the Annual Report (10-K), is a strong candidate for such a large document, although an IR could also be this large. I will default to the most comprehensive yearly filing, 10-K, as the most probable classification for a document of this magnitude, acknowledging the low confidence due to content obfuscation. Q3 2024
2025-03-27 Polish
Sprawozdanie Zarządu z działalności (jednostkowe) pdf
Management Reports Classification · 99% confidence The document is titled "Sprawozdanie Zarządu z działalności SELVITA S.A. za rok obrotowy 2024" (Management Board Report on the activities of SELVITA S.A. for the financial year 2024). It contains a detailed Table of Contents listing sections such as 'Podstawowe wielkości ekonomiczno-finansowe' (Basic economic-financial figures), 'Komentarz Zarządu do wyników finansowych' (Management Board's commentary on financial results), 'Czynniki ryzyka' (Risk factors), and 'Oświadczenie o stosowaniu ładu korporacyjnego' (Statement on corporate governance). It includes comprehensive financial tables covering the full year 2024 (01.01.2024 to 31.12.2024) and comparative data for 2023, presenting both income statement and balance sheet data. This structure and content strongly indicate a comprehensive annual report, which corresponds to the definition of a 10-K filing, even though the document is in Polish and likely filed with a local regulator (the Polish equivalent of an annual report). The length (over 150,000 characters) also supports this classification over a short announcement.
2025-03-27 Polish
Letter to Shareholders from CEO of Selvita
Audit Report / Information Classification · 95% confidence The document is a letter addressed to investors and partners, signed by the CEO (Bogusław Sieczkowski) and dated March 26, 2025. It reviews performance from the previous year (2024), discusses current momentum (entering 2025), strategic initiatives (acquisitions, management changes), and provides an outlook for the near future. This content structure—a comprehensive review of the past year's performance, strategic direction, and outlook, often signed by the CEO—is characteristic of an Annual Report or a Management Discussion & Analysis (MDA) section thereof. Since it is a detailed narrative review of business trends, strategy, and financial context rather than just the formal financial statements (10-K) or a brief earnings highlight (ER), it aligns best with the Management Reports (MDA) definition, which covers management's detailed explanation of results and outlook. It is too long and detailed to be a simple Earnings Release (ER) or a Report Publication Announcement (RPA). FY 2024
2025-03-27 English
List Prezesa Zarządu do Akcjonariuszy
Management Reports Classification · 95% confidence The document is a letter addressed to shareholders ("Szanowni Państwo, Drodzy Akcjonariusze i Przyjaciele Selvity") signed by the CEO, Bogusław Sieczkowski, dated March 26, 2025. It reviews the performance of the past year (2024), discusses current trends (Q1 2025 backlog), strategic direction (acquisitions, sales force changes), and outlook for the future. This content structure—a comprehensive review and outlook from management—is characteristic of an Annual Report (10-K) or a Management Discussion & Analysis (MDA) section often included within it, or sometimes an Earnings Release (ER) if it were shorter and focused only on results. Given the depth of strategic discussion, M&A review (Pure Biologics, Pozlab), capital expenditure plans (CAPEX), and management changes (new CCO), it strongly suggests a detailed management commentary accompanying annual or significant periodic results. Since it reviews the full year 2024 and provides a forward-looking statement, it aligns best with the Management Reports (MDA) category, which covers detailed explanations of financial results, business trends, and outlook, often serving as the narrative component of a larger annual filing or a standalone detailed management report.
2025-03-27 Polish
Powiadomienie
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details share transactions (Nabycie - Acquisition) made by a member of the management board (Członek Zarządu), Dawid Radziszewski, concerning the issuer SELVITA SPÓŁKA AKCYJNA. This content directly corresponds to the definition of Director's Dealing (insider trades by executives). The specific code for this is DIRS.
2025-02-19 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.